Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

Investing.com -- Bernstein analysts highlighted a more attractive valuation for Novo Nordisk (NYSE: NVO) following recent ...

Relying solely on BMI to diagnose obesity may be outdated, say global experts. A new report calls for a more comprehensive ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

BMI falls short as a way to measure obesity. Doctors need to also determine whether body fat harms a person's health.

A new report from global experts calls for redefining obesity beyond the traditional body mass index (BMI) measurement. The ...

For people who medically qualify for this drug, it can be life-changing. Helping with weight loss and reducing the risk of ...

Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss.  GLP-1 medications were originally intended to ...